Syapse Gathers $30 Million for ‘Real World’ Cancer Data

▤ Summary

Syapse Inc., which seeks to help health systems and life sciences companies capitalize on data generated during the care of cancer patients, has raised $30 million to expand use of its technology in the U.S. and internationally. Health systems and drugmakers have data produced in clinical trials, but they also want “real world” information on how patients are faring outside of these studies. San Francisco-based Syapse uses its software to integrate various types of data, such as clinical and molecular information, so physicians...

▦ Linked Companies

Syapse

$10M to $25M